参考文献/References:
[1] Lei JJ, Li HQ, Mo ZH, et al. Long noncoding RNA CDKN2B-AS1 interacts with transcription factor BCL11A to regulate progression of cerebral infarction through mediating MAP4K1 transcription[J]. FASEB J, 2019, 33(6): 7037-7048.
[2] Guo S, Lin Y, Ma X, et al. Long-Term safety and efficacy of antiplatelet therapy in patients with cerebral infarction with thrombocytopenia[J]. Clin Appl Thromb Hemost, 2021, 27(1): 1076029620980067.
[3] Cao W, Liu JN, Liu Z, et al. A three-lncRNA signature derived from the Atlas of ncRNA in cancer(TANRIC)database predicts the survival of patients with head and neck squamous cell carcinoma[J]. Oral Oncol, 2017, 65(1): 94-101.
[4] 黄丽丹,陶华,陈润森,等.非编码RNA与缺血性脑卒中后血管新生的研究进展[J].海南医学,2020,31(7):914-918.
[5] Qi X, Shao M, Sun H, et al. Long non-coding RNA SNHG14 promotes microglia activation by regulating miR-145-5p/PLA2G4A in cerebral infarction[J]. Neuroscience, 2017, 348(348): 98-106.
[6] 张信远,李德珠,林瑶,等.lncRNA NEAT1在中枢神经系统疾病中的研究进展[J].生物化学与生物物理进展,2020,47(11):1174-1182.
[7] 邴艳萍,宋璇,姜楠,等.lncRNA NEAT1调控miR-206对缺氧复氧大鼠心肌细胞氧化应激损伤和凋亡的影响[J].中国动脉硬化杂志,2020,28(12):1034-1041.
[8] 周倩,李双阳,徐萍,等.NEAT1通过miR-504-5p调控主动脉粥样硬化模型细胞生物学功能[J].中国老年学杂志,2021,41(19):4367-4373.
[9] 赵丽贤,朱慧,阎文静,等.脑小血管病总体负担对大动脉粥样硬化型脑梗死患者长期预后的影响[J].中风与神经疾病杂志,2020,37(4):292-297.
[10] Wang H, Lu H, Zhang XM, et al. Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction[J]. BMC Neurol, 2021, 21(1): 274.
[11] 胡冬梅.脑梗死患者血清NSE、Lp-PLA2、Hcy水平变化及意义分析[J].现代诊断与治疗,2020,31(23):3813-3815.
[12] 袁凤英,孙少康,金智生.长非编码RNA NEAT1在糖尿病及其并发症中的分子调控机制[J/OL].中国生物化学与分子生物学报,2022,38(2):159-164.
[13] 钟潇,黄龙,朱蜀侠.lncRNA-NEAT1靶向miR-34 a抑制肾癌细胞生长的实验研究[J].现代肿瘤医学,2022,30(3):376-382.
[14] Huang S, Qian K, Zhu Y, et al. Diagnostic value of the lncRNA NEAT1 in peripheral blood mononuclear cells of patients with sepsis[J]. Dis Markers, 2017(16): 7962836.
[15] 王晨,杜彦廷,张莹.宿主lncRNA在病毒感染中的作用研究进展[J].动物医学进展,2021,42(11):100-105.
[16] 孙骏,肖亮,宋健博.长链非编码RNA NEAT1对血管平滑肌细胞增殖和凋亡的影响及作用机制[J].中国医科大学学报,2020,49(7):601-605.
[17] 马靖,丁宁,袁小丽,等.急性心肌梗死患者外周血长链非编码核糖核酸NEAT1表达水平与病情及预后的相关性分析[J].心肺血管病杂志,2021,40(10):1020-1024.
[18] Li P, Duan S, Fu A. Long noncoding RNA NEAT1 correlates with higher disease risk, worse disease condition, decreased miR-124 and miR-125a and predicts poor recurrence-free survival of acute ischemic stroke[J]. J Clin Lab Anal, 2020, 34(2): e23056.
[19] Bian W, Chen W, Jiang X, et al. Downregulation of long non-coding RNA nuclear paraspeckle assembly transcript 1 inhibits MEG-01 differentiation and Platelet-Like particles activity[J]. Front Genet, 2020, 11(11): 571467.
[20] 孙淑君,王茹莹,钟真真,等.抗栓前后血小板参数对非心源性脑梗死预后预测价值研究[J].国际神经病学神经外科学杂志,2021,48(1):55-58.
相似文献/References:
[1]陈宇,姜春香,刁彦君,等.大脑中动脉供血区梗死后运动功能与FA比值的相关性研究[J].卒中与神经疾病杂志,2015,22(01):9.
[2]李锦师,陆练军,沈健,等.MMP-9在扩大时间窗急性脑梗死静脉溶栓出血转化中的意义[J].卒中与神经疾病杂志,2015,22(01):18.
[3]徐晓琳,吴岑,冯娟,等.急性脑梗死患者90d预后的相关因素分析[J].卒中与神经疾病杂志,2015,22(01):21.
[4]张兆辉,张清,何国厚,等.重组织型纤溶酶原激活剂联合依达拉奉治疗急性脑梗死的系统评价[J].卒中与神经疾病杂志,2015,22(01):36.
[5]赵媛,冯凯.脑梗死急性期合并肺栓塞的临床特点分析——附11例报道[J].卒中与神经疾病杂志,2015,22(03):141.
[6]包正军,刘琳.急性脑梗死患者血清尿酸水平与颈动脉粥样硬化的关系研究[J].卒中与神经疾病杂志,2015,22(03):160.
[7]林志坚,车秀娟,程欣,等.脑梗死患者阿司匹林抵抗与复发缺血性血管事件风险[J].卒中与神经疾病杂志,2015,22(03):163.
[8]谢龙舟,陈爱,徐靖文,等.奥拉西坦治疗脑梗死患者认知障碍的疗效观察[J].卒中与神经疾病杂志,2015,22(03):177.
[9]唐向阳,袁良津,蒋鸣坤,等.重复经颅磁刺激对脑梗死后轻度认知功能损害患者的研究[J].卒中与神经疾病杂志,2015,22(02):76.
[10]职瑾,裴纪文,段斌,等.不同剂量叶酸对脑梗死患者血同型半胱氨酸水平的影响[J].卒中与神经疾病杂志,2014,21(06):381.